Coronavirus disease 2019 (COVID-19)
Situation Report - 71
St World Health
Organization
fS
Data as reported by national authorities by 10:00 CET 31 March 2020
HIGHLIGHTS
• No new countries/territories/areas reported cases of COVID-19 in the past 24
hours.
• As mentioned by the Director-General in his regular media briefing yesterday,
ensuring free movement of essential health products is vital for saving lives
and curbing the social and economic impacts of the pandemic. WHO is
working intensively with partners to increase access to life-saving products,
including diagnostics, PPE, medical oxygen, ventilators and more. For more
information: https://www.who.int/dg/speeches/detail/who-director-general-
s-opening-remarks-at-the-media-briefing-on-covid-19—30-march-2020
• Operations support and logistics continues to monitor critical markets and in
partnership with the Pandemic Supply Chain Network, has increased
engagement and coordination with private companies. Since the beginning of
the outbreak, OSL has shipped more than 800 000 surgical masks, 54 000 N95
masks, 873 000 gloves, 15 000 goggles and 24 000 face shields to 75 countries.
OSL has also shipped COVID-19 testing kits to 126 countries. For more details,
please see 'subject in focus'.
SITUATION IN NUMBERS
total (new) cases in last 24 hours
Globally
750 890 confirmed (57 610)
36 405 deaths (3301)
Western Pacific Region
104 868 confirmed (1093)
3671 deaths (22)
European Region
423 946 confirmed (31131)
26 694 deaths (2733)
South-East Asia Region
4215 confirmed (131)
166 deaths (8)
Eastern Mediterranean Region
50 349 confirmed (4020)
2954 deaths (142)
Region of the Americas
163 014 confirmed (20 935)
2836 deaths (379)
African Region
3786 confirmed (300)
77 deaths (17)
WHO RISK ASSESSMENT
Global Level Very High
Figure 1. Countries, territories or areas with reported confirmed cases of COVID-19, 31 March 2020
Countries, areas or territories with COVID-19 cases reported in the last 7 days, WnrIH Health
as of 31 March 2020, 10:00 (CET) Organization
Number of cases of Serbia and Kosovo (UNSCR 1 244, 1999)
have been aggregated for visualization purposes.
Data Source- World Health Organization
Map Production ■ WHO Health Emergencies Programme
Country, area or territory with no cases reported
in the last 7 days
Country, area or territory without cases
The boundaries and names shown and the designations used on this map do not imply the expression of any
opinion whatsoever on the part of the World Health Organization concerning the legal status of ony country,
territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted
and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.
Not applicable
©World Health Organization 2020, All rights reserved
SUBJECT IN FOCUS: WHO Strengthens supply chains and releases guidance on setting up
treatment centres
WHO Operations Support and Logistics (OSL) continues to support the COVID-19 emergency operations despite
continued disruption to critical supply markets where demand outpaces global supply.
Since the beginning of the outbreak, OSL has shipped more than 800 000 surgical masks, 54 000 N95 masks, 873 000
gloves, 15 000 goggles and 24 000 face shields to 75 countries. OSL has also shipped COVID-19 testing kits to 126
countries.
A Supply Chain Inter-Agency Coordination Cell (SCICC) has been established to provide an overview of supply chain
requirements and ensure that COVID-19 needs are prioritized within the wider humanitarian response. The SCICC has
established a Supply and Market Working Group to streamline procurement of critical supplies and equipment to
address global shortages.
A common platform for private-sector donations of critical items in support of the COVID-19 response will be
announced shortly. The list of critical items is available online.
OSL continues to monitor critical markets and has increased engagement and coordination with private companies,
in partnership with the Pandemic Supply Chain Network.
OSL has released the first edition of a practical manual to set up and manage a Severe Acute Respiratory Infection
(SARI) treatment centre and a SARI screening facility in health-care facilities. The manual is available online, and
accompanying training modules are available to the public through Open WHO.
■ Module 1: Overview of basic operational and IPC principles in COVID-19 context
■ Module 2: Designing a SARI screening area and treatment centre
■ Module 3: Repurposing an existing building into a SARI treatment centre
An additional module for WASH (water, sanitation and hygiene), waste management, energy requirements and
installations for SARI facilities is currently under development.
OSL is also working to build tactical infection prevention and control (IPC) surge support to hospitals with an aim to
help improve infectious disease management protocols, limit nosocomial transmission and support rational
consumption of personal protective equipment.
SURVEILLANCE
Table 1. Countries, territories or areas with reported laboratory-confirmed COVID-19 cases and deaths. Data as of
31 March 2020*
Reporting Country/
Territory/Area +
Total
confirmed
* cases
Total
confirmed
new cases
Total
deaths
Total
new
deaths
Transmission
classification 9
Days since last
reported case
Western Pacific Region
China
82545
98
3314
4
Local transmission
0
Republic of Korea
9786
125
162
4
Local transmission
0
Australia
4359
393
18
2
Local transmission
0
Malaysia
2626
156
37
3
Local transmission
0
Japan
1953
87
56
2
Local transmission
0
Philippines
1546
128
78
7
Local transmission
0
Singapore
879
35
3
0
Local transmission
0
New Zealand
600
48
1
0
Local transmission
0
Viet Nam
203
15
0
0
Local transmission
0
Brunei Darussalam
127
1
1
0
Local transmission
0
Cambodia
107
4
0
0
Local transmission
0
Mongolia
12
0
0
0
Imported cases only
3
Lao People's
Democratic Republic
8
0
0
0
Local transmission
1
Fiji
5
0
0
0
Local transmission
5
Papua New Guinea
1
0
0
0
Imported cases only
10
Territories"
Guam
58
2
1
0
Local transmission
0
French Polynesia
36
1
0
0
Local transmission
0
New Caledonia
15
0
0
0
Local transmission
3
Northern Mariana
Islands
(Commonwealth of
the)
2
0
0
0
Under investigation
2
European Region
Italy
101739
4050
11591
810
Local transmission
0
Spain
85195
6398
7340
812
Local transmission
0
Germany
61913
4615
583
128
Local transmission
0
France
43977
4335
3017
415
Local transmission
0
The United Kingdom
22145
2619
1408
180
Local transmission
0
Switzerland
15412
1138
295
38
Local transmission
0
Belgium
11899
1063
513
82
Local transmission
0
Netherlands
11750
884
864
93
Local transmission
0
Turkey
10827
1556
168
37
Local transmission
0
Austria
9618
805
108
22
Local transmission
0
Portugal
6408
446
140
21
Local transmission
0
Israel
4831
584
17
2
Local transmission
0
Norway
4226
124
26
4
Local transmission
0
Sweden
4028
328
146
36
Local transmission
0
Czechia
3002
173
24
8
Local transmission
0
Ireland
2910
295
54
8
Local transmission
0
Denmark
2577
182
77
5
Local transmission
0
Poland
2055
193
31
9
Local transmission
0
Luxembourg
1988
38
22
1
Local transmission
0
Romania
1952
192
44
4
Local transmission
0
Russian Federation
1837
303
9
0
Local transmission
0
Finland
1313
95
13
2
Local transmission
0
Greece
1212
56
43
5
Local transmission
0
Iceland
1086
66
2
0
Local transmission
0
Croatia
790
77
6
0
Local transmission
0
Serbia
785
44
13
0
Local transmission
0
Slovenia
763
33
11
0
Local transmission
0
Estonia
715
36
3
0
Local transmission
0
Ukraine
549
69
13
2
Local transmission
0
Lithuania
484
0
7
0
Local transmission
1
Armenia
482
0
3
0
Local transmission
1
Hungary
447
0
15
0
Local transmission
1
Latvia
376
0
0
0
Local transmission
1
Andorra
370
29
8
2
Local transmission
0
Bosnia and
Herzegovina
359
34
9
3
Local transmission
0
Bulgaria
359
13
8
0
Local transmission
0
Slovakia
336
0
0
0
Local transmission
1
Kazakhstan
312
18
1
0
Local transmission
0
Republic of Moldova
298
35
2
0
Local transmission
0
North Macedonia
285
26
7
1
Local transmission
0
Azerbaijan
273
83
4
0
Local transmission
0
Cyprus
230
16
7
1
Local transmission
0
San Marino
230
1
25
1
Local transmission
0
Albania
223
0
11
1
Local transmission
1
Malta
156
5
0
0
Local transmission
0
Belarus
152
0
0
0
Local transmission
1
Uzbekistan
149
4
2
0
Local transmission
0
Kyrgyzstan
107
23
0
0
Local transmission
0
Georgia
103
5
0
0
Local transmission
0
Montenegro
91
6
1
0
Local transmission
0
Liechtenstein
64
2
0
0
Under investigation
0
Monaco
49
3
0
0
Local transmission
0
Holy See
6
0
0
0
Under investigation
1
Territories”
Faroe Islands
168
9
0
0
Local transmission
0
Kosovo 111
106
12
1
0
Local transmission
0
Gibraltar
69
4
0
0
Local transmission
0
Jersey
63
0
2
0
Local transmission
1
Guernsey
45
6
0
0
Local transmission
0
Isle of Man
42
0
0
0
Local transmission
1
Greenland
10
0
0
0
Under investigation
2
South-East Asia Region
Thailand
1524
0
9
0
Local transmission
1
Indonesia
1414
129
122
8
Local transmission
0
India
1071
0
29
0
Local transmission
1
Sri Lanka
120
0
1
0
Local transmission
1
Bangladesh
49
0
5
0
Local transmission
1
Maldives
17
0
0
0
Local transmission
1
Myanmar
10
2
0
0
Local transmission
0
Nepal
5
0
0
0
Imported cases only
2
Bhutan
4
0
0
0
Imported cases only
1
Timor-Leste
1
0
0
0
Under investigation
10
Eastern Mediterranean Region
Iran (Islamic Republic
of)
41495
3186
2757
117
Local transmission
0
Pakistan
1865
240
25
7
Local transmission
0
Saudi Arabia
1453
154
8
0
Local transmission
0
Qatar
693
59
1
0
Local transmission
0
Egypt
656
47
41
1
Local transmission
0
Iraq
630
83
46
4
Local transmission
0
United Arab Emirates
611
41
5
2
Local transmission
0
Morocco
574
58
33
6
Local transmission
0
Bahrain
515
0
4
0
Local transmission
1
Lebanon
446
8
11
1
Local transmission
0
Tunisia
362
50
9
1
Local transmission
0
Jordan
268
9
5
2
Local transmission
0
Kuwait
266
11
0
0
Local transmission
0
Oman
179
12
0
0
Local transmission
0
Afghanistan
166
52
4
0
Local transmission
0
Djibouti
26
7
0
0
Local transmission
0
Syrian Arab Republic
10
1
2
1
Imported cases only
0
Libya
8
0
0
0
Local transmission
1
Sudan
6
0
2
0
Imported cases only
1
Somalia
3
0
0
0
Imported cases only
4
Territories”
occupied Palestinian
territory
117
2
1
0
Local transmission
0
Region of the Americas
United States of
America
140640
17987
2398
286
Local transmission
0
Canada
6317
662
66
5
Local transmission
0
Brazil
4256
352
136
22
Local transmission
0
Chile
2449
540
8
2
Local transmission
0
Ecuador
1962
127
60
12
Local transmission
0
Mexico
993
145
20
4
Local transmission
0
Panama
989
88
24
7
Local transmission
0
Dominican Republic
901
320
42
22
Local transmission
0
Peru
852
181
11
0
Local transmission
0
Argentina
820
75
20
1
Local transmission
0
Colombia
702
94
10
4
Local transmission
0
Costa Rica
314
19
2
0
Local transmission
0
Uruguay
309
6
0
0
Local transmission
0
Cuba
170
51
4
1
Local transmission
0
Honduras
139
29
2
0
Local transmission
0
Venezuela (Bolivarian
Republic of)
129
16
3
1
Local transmission
0
Bolivia (Plurinational
State of)
97
23
5
5
Local transmission
0
Trinidad and Tobago
82
6
3
0
Local transmission
0
Paraguay
64
5
3
0
Local transmission
0
Guatemala
36
2
1
0
Local transmission
0
Jamaica
36
4
1
0
Local transmission
0
Barbados
33
7
0
0
Local transmission
0
El Salvador
30
6
0
0
Local transmission
0
Haiti
15
0
0
0
Imported cases only
1
Bahamas
14
4
0
0
Local transmission
0
Cayman Islands
12
4
1
0
Imported cases only
0
Grenada
9
2
0
0
Local transmission
0
Saint Lucia
9
5
0
0
Local transmission
0
Guyana
8
3
1
0
Local transmission
0
Suriname
8
0
0
0
Imported cases only
3
Antigua and Barbuda
7
0
0
0
Imported cases only
3
Nicaragua
4
0
1
0
Imported cases only
2
Belize
3
1
0
0
Local transmission
0
Saint Kitts and Nevis
2
0
0
0
Imported cases only
0
Saint Vincent and the
Grenadines
1
0
0
0
Imported cases only
18
Territories**
Puerto Rico
174
110
6
4
Imported cases only
0
Martinique
111
6
2
0
Local transmission
0
Guadeloupe
106
10
4
2
Imported cases only
0
Aruba
50
4
0
0
Local transmission
0
French Guiana
43
12
0
0
Local transmission
0
United States Virgin
Islands
30
8
0
0
Imported cases only
0
Bermuda
22
0
0
0
Local transmission
1
Saint Martin
18
12
1
1
Under investigation
0
Curasao
11
4
1
0
Imported cases only
0
Dominica
11
0
0
0
Local transmission
4
Saint Barthelemy
6
1
0
0
Under investigation
0
Sint Maarten
6
3
0
0
Imported cases only
0
Montserrat
5
0
0
0
Imported cases only
3
Turks and Caicos
Islands
5
1
0
0
Local transmission
0
Anguilla
2
0
0
0
Local transmission
4
British Virgin Islands
2
0
0
0
Imported cases only
4
African Region
South Africa
1326
46
3
2
Local transmission
0
Algeria
511
57
31
2
Local transmission
0
Burkina Faso
246
24
12
9
Local transmission
0
Cote d'Ivoire
169
4
0
0
Local transmission
0
Senegal
162
20
0
0
Local transmission
0
Ghana
152
0
5
0
Local transmission
1
Cameroon
139
26
6
4
Local transmission
0
Nigeria
111
46
1
0
Local transmission
0
Mauritius
107
5
2
0
Local transmission
0
Democratic Republic
of the Congo
98
17
8
0
Local transmission
0
Rwanda
70
0
0
0
Local transmission
1
Madagascar
46
9
0
0
Imported cases only
0
Kenya
38
13
1
0
Local transmission
0
Zambia
35
19
0
0
Local transmission
0
Togo
34
6
1
0
Local transmission
0
Uganda
33
0
0
0
Local transmission
1
Ethiopia
23
2
0
0
Local transmission
0
Niger
20
0
3
0
Local transmission
1
Congo
19
0
0
0
Imported cases only
3
United Republic of
Tanzania
19
5
0
0
Under investigation
0
Mali
18
0
0
0
Local transmission
2
Guinea
16
0
0
0
Local transmission
1
Equatorial Guinea
14
1
0
0
Local transmission
0
Namibia
11
0
0
0
Imported cases only
1
Eswatini
9
0
0
0
Imported cases only
3
Mozambique
8
0
0
0
Local transmission
2
Seychelles
8
0
0
0
Imported cases only
1
Gabon
7
0
1
0
Imported cases only
3
Benin
6
0
0
0
Imported cases only
4
Central African
Republic
6
0
0
0
Imported cases only
3
Eritrea
6
0
0
0
Imported cases only
4
Cabo Verde
5
0
1
0
Imported cases only
3
Chad
5
0
0
0
Imported cases only
4
Mauritania
5
0
0
0
Imported cases only
2
Zimbabwe
5
0
1
0
Local transmission
3
Gambia
3
0
1
0
Imported cases only
2
Liberia
3
0
0
0
Local transmission
9
Angola
2
0
0
0
Imported cases only
9
Guinea-Bissau
2
0
0
0
Imported cases only
5
Territories”
Reunion
207
0
0
0
Local transmission
1
Mayotte
82
0
0
0
Local transmission
1
Subtotal for all
regions
750178
57610
36398
3301
International
conveyance (Diamond
Princess)
712
0
7
0
Local transmission
15
Grand total
750890
57610
36405
3301
Numbers include both domestic and repatriated cases
+ The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on
the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its
frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.
♦Case classifications are based on WHO case definitions for COVID-19.
transmission classification is based on WHO analysis of available official data and may be subject to reclassification as additional data become
available. Countries/territories/areas experiencing multiple types of transmission are classified in the highest category for which there is
evidence; they may be removed from a given category if interruption of transmission can be demonstrated. It should be noted that even within
categories, different countries/territories/areas may have differing degrees of transmission as indicated by the differing numbers of cases and
other factors. Not all locations within a given country/territory/area are equally affected.
Terms:
Community transmission is evidenced by the inability to relate confirmed cases through chains of transmission for a large number of cases, or by
increasing positive tests through sentinel samples (routine systematic testing of respiratory samples from established laboratories).
Local transmission indicates locations where the source of infection is within the reporting location.
Imported cases only indicates locations where all cases have been acquired outside the location of reporting.
Under investigation indicates locations where type of transmission has not been determined for any cases.
Interrupted transmission indicates locations where interruption of transmission has been demonstrated (details to be determined)
** "Territories" include territories, areas, overseas dependencies and other jurisdictions of similar status
[1) All references to Kosovo should be understood to be in the context of the United Nations Security Council resolution 1244 (1999).
Due to differences in reporting methods, retrospective data consolidation, and reporting delays, the number of new cases may not always
reflect the exact difference between yesterday's and today's totals. WHO COVID-19 Situation Reports present official counts of confirmed
COVID-19 cases, thus differences between WHO reports and other sources of COVID-19 data using different inclusion criteria and different
data cutoff times are to be expected.
Figure 1. Epidemic curve of confirmed COVID-19, by date of report and WHO region through 31 March 2020
2019 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020 2020
Date of report
WHO region
I Africa
Americas
■ Eastern Mediterranean
■ Europe
South-East Asia
Western Pacific
Other
STRATEGIC OBJECTIVES
WHO's strategic objectives for this response are to:
• Interrupt human-to-human transmission including reducing secondary infections among close contacts
and health care workers, preventing transmission amplification events, and preventing further
international spread*;
• Identify, isolate and care for patients early, including providing optimized care for infected patients;
• Identify and reduce transmission from the animal source;
• Address crucial unknowns regarding clinical severity, extent of transmission and infection, treatment
options, and accelerate the development of diagnostics, therapeutics and vaccines;
• Communicate critical risk and event information to all communities and counter misinformation;
• Minimize social and economic impact through multisectoral partnerships.
*This can be achieved through a combination of public health measures, such as rapid identification, diagnosis
and management of the cases, identification and follow up of the contacts, infection prevention and control in
health care settings, implementation of health measures for travelers, awareness-raising in the population and
risk communication.
PREPAREDNESS AND RESPONSE
• To view all technical guidance documents regarding COVID-19, please go to this webpage .
• WHO has developed interim guidance forjaboratory diagnosis, advice on the use of masks during home care and
in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak, clinical management,
infection prevention and control in health care settings, home care for patients with suspected novel
coronavirus, risk communication and community engagement and Global Surveillance for human infection with
novel coronavirus (2019-nCoV).
• WHO is working closely with International Air Transport Association (IATA) and have jointly developed a
guidance document to provide advice to cabin crew and airport workers, based on country queries. The
guidance can be found on the IATA webpage .
• WHO has been in regular and direct contact with Member States where cases have been reported. WHO is also
informing other countries about the situation and providing support as requested.
• WHO is working with its networks of researchers and other experts to coordinate global work on surveillance,
epidemiology, mathematical modelling, diagnostics and virology, clinical care and treatment, infection
prevention and control, and risk communication. WHO has issued interim guidance for countries, which are
updated regularly.
• WHO has prepared a disease commodity package that includes an essential list of biomedical equipment,
medicines and supplies necessary to care for patients with 2019-nCoV.
• WHO has provided recommendations to reduce risk of transmission from animals to humans .
• WHO has published an updated advice for international traffic in relation to the outbreak of the novel
coronavirus 2019-nCoV .
• WHO has activated the R&D blueprint to accelerate diagnostics, vaccines, and therapeutics.
• OpenWHO is an interactive, web-based, knowledge-transfer platform offering online courses to improve the
response to health emergencies. COVID-19 courses can be found here and courses in additional national
languages here . Specifically, WHO has developed online courses on the following topics:
o A general introduction to emerging respiratory viruses, including novel coronaviruses (available in
Arabic, Chinese, English, French, Russian, Spanish, Hindi, Indian Sign Language, Persian, Portuguese,
Serbian and Turkish);
o Clinical care for Severe Acute Respiratory Infections (available in English, French, Russian, Indonesian
and Vietnamese);
o Health and safety briefing for respiratory diseases - ePROTECT (available in Chinese, English, French,
Russian, Spanish, Indonesian and Portuguese);
o Infection Prevention and Control for Novel Coronavirus (COVID-19) (available in Chinese, English, French,
Russian, Spanish, Indonesian, Italian, Japanese, Portuguese and Serbian); and
o COVID-19 Operational Planning Guidelines and COVID-19 Partners Platform to support country
preparedness and response (available in English and coming soon in additional languages).
• WHO is providing guidance on early investigations, which are critical in an outbreak of a new virus. The data
collected from the protocols can be used to refine recommendations for surveillance and case definitions, to
characterize the key epidemiological transmission features of COVID-19, help understand spread, severity,
spectrum of disease, impact on the community and to inform operational models for implementation of
countermeasures such as case isolation, contact tracing and isolation. Several protocols are available here . One
such protocol is for the investigation of early COVID-19 cases and contacts (the " First Few X (FFX) Cases and
contact investigation protocol for 2019-novel coronavirus (2019-nCoV) infection "). The protocol is designed to
gain an early understanding of the key clinical, epidemiological and virological characteristics of the first cases of
COVID-19 infection detected in any individual country, to inform the development and updating of public health
guidance to manage cases and reduce the potential spread and impact of infection.
RECOMMENDATIONS AND ADVICE FOR THE PUBLIC
If you are not in an area where COVID-19 is spreading or have not travelled from an area where COVID-19 is
spreading or have not been in contact with an infected patient, your risk of infection is low. It is understandable that
you may feel anxious about the outbreak. Get the facts from reliable sources to help you accurately determine your
risks so that you can take reasonable precautions (see Frequently Asked Questions ). Seek guidance from WHO, your
healthcare provider, your national public health authority or your employer for accurate information on COVID-19
and whether COVID-19 is circulating where you live. It is important to be informed of the situation and take
appropriate measures to protect yourself and your family (see Protection measures for everyone) .
If you are in an area where there are cases of COVID-19 you need to take the risk of infection seriously. Follow the
advice of WHO and guidance issued by national and local health authorities. For most people, COVID-19 infection
will cause mild illness however, it can make some people very ill and, in some people, it can be fatal. Older people,
and those with pre-existing medical conditions (such as cardiovascular disease, chronic respiratory disease or
diabetes) are at risk for severe disease (See Protection measures for persons who are in or have recently visited (past
14 days) areas where COVID-19 is spreading ).
CASE DEFINITIONS
WHO periodically updates the Global Surveillance for human infection with coronavirus disease (COVID-19)
document which includes case definitions.
For easy reference, case definitions are included below.
Suspect case
A. A patient with acute respiratory illness (fever and at least one sign/symptom of respiratory disease, e.g., cough,
shortness of breath), AND a history of travel to or residence in a location reporting community transmission of
COVID-19 disease during the 14 days prior to symptom onset.
OR
B. A patient with any acute respiratory illness AND having been in contact with a confirmed or probable COVID-19
case (see definition of contact) in the last 14 days prior to symptom onset;
OR
C. A patient with severe acute respiratory illness (fever and at least one sign/symptom of respiratory disease, e.g.,
cough, shortness of breath; AND requiring hospitalization) AND in the absence of an alternative diagnosis that
fully explains the clinical presentation.
Probable case
A. A suspect case for whom testing for the COVID-19 virus is inconclusive.
a. Inconclusive being the result of the test reported by the laboratory.
OR
B. A suspect case for whom testing could not be performed for any reason.
Confirmed case
A person with laboratory confirmation of COVID-19 infection, irrespective of clinical signs and symptoms.
• Technical guidance for laboratory testing can be found here .
Definition of contact
A contact is a person who experienced any one of the following exposures during the 2 days before and the 14 days
after the onset of symptoms of a probable or confirmed case:
1. Face-to-face contact with a probable or confirmed case within 1 meter and for more than 15 minutes;
2. Direct physical contact with a probable or confirmed case;
3. Direct care for a patient with probable or confirmed COVID-19 disease without using proper personal
protective equipment 1 ; OR
4. Other situations as indicated by local risk assessments.
Note: for confirmed asymptomatic cases, the period of contact is measured as the 2 days before through the 14 days
after the date on which the sample was taken which led to confirmation.
1 World Health Organization. Infection prevention and control during health care when COVID-19 is suspected
https://www.who.int/publications-detail/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-
infection-is-suspected-20200125
